Nanolec: Herpes zoster vaccine

2023: Herpes zoster vaccine announcement

In March 2023, it became known that the Russian pharmaceutical company Nanolek"" began to create the country's first zoster vaccine. herpes Work is underway in the Pushchino science city near Moscow, where the company opened the Research and Development Center in 2021.

In Russia, at the moment there is not a single registered vaccine against this disease. Our task is to develop the first domestic antigen, completely similar to the original drug. Preclinical studies are currently underway to assess the efficacy and safety of the vaccine. After their completion, if a positive result is obtained, we will begin to create stable cell lines and conduct registration preclinical studies, "said Svetlana Zakirova, Deputy General Director of Nanolek for Research and Development. Her words on March 20, 2023 are quoted by the Pushchinskaya Sreda publication.

Nanolek announced the creation of the first herpes zoster vaccine in Russia

Herpes zoster, also known as shingles, a viral disease that causes the herpesvirus family chickenpox virus, is the same pathogen as "chickenpox." But if chickenpox is more common in childhood, then herpes zoster threatens the elderly - over 65 years old.

The disease manifests itself as characteristic painful rashes, usually on one side of the body. More often they occur in the area of ​ ​ the intercostal or trigeminal nerve, which are also affected by the virus, provoking a pain syndrome and greatly worsening the quality of life. Those who suffered chickenpox in childhood are also susceptible to diseases.^[1]

Notes